Chemours Co Stock Filter Stocks by Fundamentals
| CC Stock | USD 14.15 0.30 2.08% |
Chemours Co fundamentals help investors to digest information that contributes to Chemours' financial success or failures. It also enables traders to predict the movement of Chemours Stock. The fundamental analysis module provides a way to measure Chemours' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Chemours stock.
Chemours | Shares Owned by Institutions |
Chemours Current Valuation Drivers
We derive many important indicators used in calculating different scores of Chemours from analyzing Chemours' financial statements. These drivers represent accounts that assess Chemours' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Chemours' important valuation drivers and their relationship over time.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Market Cap | 3.0B | 4.1B | 4.8B | 4.7B | 2.5B | 4.8B | |
| Enterprise Value | 6.4B | 7.3B | 7.5B | 7.8B | 6.2B | 5.3B |
Chemours ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Chemours' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Chemours' managers, analysts, and investors.Environmental | Governance | Social |
Chemours Institutional Holders
Institutional Holdings refers to the ownership stake in Chemours that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Chemours' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Chemours' value.| Shares | Ubs Group Ag | 2024-12-31 | 2.1 M | Norges Bank | 2024-12-31 | 1.8 M | Dimensional Fund Advisors, Inc. | 2024-12-31 | 1.8 M | American Century Companies Inc | 2024-12-31 | 1.6 M | Massachusetts Financial Services Company | 2024-12-31 | 1.6 M | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 1.6 M | Mackenzie Investments | 2024-12-31 | 1.6 M | Vision One Management Partners Lp | 2024-12-31 | 1.6 M | Scopia Management Inc | 2024-12-31 | 1.4 M | Blackrock Inc | 2024-12-31 | 16.8 M | Vanguard Group Inc | 2024-12-31 | 15.2 M |
Chemours Fundamentals
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0349 | ||||
| Profit Margin | 0.01 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 5.8 B | ||||
| Shares Outstanding | 149.44 M | ||||
| Shares Owned By Insiders | 0.42 % | ||||
| Shares Owned By Institutions | 85.79 % | ||||
| Number Of Shares Shorted | 8.81 M | ||||
| Price To Earning | 25.49 X | ||||
| Price To Book | 3.58 X | ||||
| Price To Sales | 0.37 X | ||||
| Revenue | 5.78 B | ||||
| Gross Profit | 1.15 B | ||||
| EBITDA | 692 M | ||||
| Net Income | 86 M | ||||
| Cash And Equivalents | 1.1 B | ||||
| Cash Per Share | 7.73 X | ||||
| Total Debt | 4.36 B | ||||
| Debt To Equity | 2.94 % | ||||
| Current Ratio | 1.82 X | ||||
| Book Value Per Share | 4.04 X | ||||
| Cash Flow From Operations | (633 M) | ||||
| Short Ratio | 4.29 X | ||||
| Earnings Per Share | 0.57 X | ||||
| Price To Earnings To Growth | 1.67 X | ||||
| Target Price | 22.2 | ||||
| Number Of Employees | 6 K | ||||
| Beta | 1.98 | ||||
| Market Capitalization | 2.16 B | ||||
| Total Asset | 7.51 B | ||||
| Retained Earnings | 1.72 B | ||||
| Working Capital | 1.22 B | ||||
| Current Asset | 2.3 B | ||||
| Current Liabilities | 1.47 B | ||||
| Annual Yield | 0.07 % | ||||
| Five Year Return | 3.59 % | ||||
| Net Asset | 7.51 B | ||||
| Last Dividend Paid | 1.0 |
About Chemours Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Chemours Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Chemours using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Chemours Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Chemours Piotroski F Score and Chemours Altman Z Score analysis. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Diversified Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Chemours. If investors know Chemours will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Chemours listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.65) | Dividend Share 1 | Earnings Share 0.57 | Revenue Per Share | Quarterly Revenue Growth (0.01) |
The market value of Chemours is measured differently than its book value, which is the value of Chemours that is recorded on the company's balance sheet. Investors also form their own opinion of Chemours' value that differs from its market value or its book value, called intrinsic value, which is Chemours' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Chemours' market value can be influenced by many factors that don't directly affect Chemours' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Chemours' value and its price as these two are different measures arrived at by different means. Investors typically determine if Chemours is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Chemours' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.